ROSSARI — Rossari Biotech Share Price
- IN₹38.23bn
- IN₹39.00bn
- IN₹18.31bn
- 66
- 14
- 18
- 20
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 24.22 | ||
PEG Ratio (f) | 1.65 | ||
EPS Growth (f) | 17.26% | ||
Dividend Yield (f) | 0.15% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 3.46 | ||
Price to Tang. Book | 4.49 | ||
Price to Free Cashflow | 2,317.09 | ||
Price to Sales | 1.96 | ||
EV to EBITDA | 15.16 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 15.51% | ||
Return on Equity | 12.98% | ||
Operating Margin | 9.9% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | 6,000.94 | 7,093.45 | 14,829.74 | 16,558.81 | 18,305.58 | 20,359 | 23,446.25 | 28.81% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +42.91 | +19.74 | +10.28 | +13.84 | +20.86 | +5.36 | +17.26 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Rossari Biotech Limited is an India-based company. The Company is engaged in manufacturing, selling and distribution of specialty chemicals. The products cater to global brands in the FMCG sector and find applications in a host of consumer centric products and home and personal care products, textile chemicals, animal health and nutrition and cosmetic products. It operates through three segments: Home, Personal Care and Performance Chemicals (HPPC), Textile Specialty Chemicals (TSC), and Animal Health and Nutrition (AHN). HPPC produces acrylic polymers, manufacturing a sustainable range of products for various applications in the cleaning industry. TSC is focused on providing customers with eco-friendly, sustainable chemical solutions. It provides solutions for pre-treatment, dyeing and printing, finishing, and specialty chemicals for the entire value chain of the textile industry. AHN provides wellness solutions for pet animals and poultry, focusing on their health and performance.
Directors
- Edward Menezes CHM
- Sunil Chari CFD
- Manasi Nisal CFO
- Parul Gupta CCO
- Robin Banerjee IND (66)
- Goutam Bhattacharya IND
- Meher Castelino IND
- Aseem Dhru IND (50)
- Sharabh Pachory IND
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 10th, 2009
- Public Since
- July 23rd, 2020
- No. of Shareholders
- 100,607
- No. of Employees
- 450
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
National Stock Exchange of India
- Shares in Issue
- 55,363,766

- Address
- Lbs Marg, Next To Ge Gardens, Kanjurmarg, MUMBAI, 400078
- Web
- https://www.rossari.com/
- Phone
- +91 2261233800
- Contact
- Parul Gupta
- Auditors
- For Walker Chandiok & CoLLP
Upcoming Events for ROSSARI
Rossari Biotech Ltd Annual Shareholders Meeting
Q2 2026 Rossari Biotech Ltd Earnings Release
Similar to ROSSARI
20 Microns
National Stock Exchange of India
Aarti Industries
National Stock Exchange of India
Aarti Surfactants
National Stock Exchange of India
Abm International
National Stock Exchange of India
Advanced Enzyme Technologies
National Stock Exchange of India
FAQ
As of Today at 22:59 UTC, shares in Rossari Biotech are trading at IN₹699.35. This share price information is delayed by 15 minutes.
Shares in Rossari Biotech last closed at IN₹699.35 and the price had moved by -8.17% over the past 365 days. In terms of relative price strength the Rossari Biotech share price has underperformed the S&P BSE 100 Index by -13.5% over the past year.
The overall consensus recommendation for Rossari Biotech is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Rossari Biotech dividend yield is 0.07% based on the trailing twelve month period.
Last year, Rossari Biotech paid a total dividend of IN₹0.50, and it currently has a trailing dividend yield of 0.07%. We do not have any data on when Rossari Biotech is to next pay dividends.
We do not have data on when Rossari Biotech is to next pay dividends. The historic dividend yield on Rossari Biotech shares is currently 0.07%.
To buy shares in Rossari Biotech you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹699.35, shares in Rossari Biotech had a market capitalisation of IN₹38.23bn.
Here are the trading details for Rossari Biotech:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: ROSSARI
Based on an overall assessment of its quality, value and momentum Rossari Biotech is currently classified as a Falling Star. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Rossari Biotech is IN₹929.29. That is 32.88% above the last closing price of IN₹699.35.
Analysts covering Rossari Biotech currently have a consensus Earnings Per Share (EPS) forecast of IN₹24.63 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Rossari Biotech. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -6.58%.
As of the last closing price of IN₹699.35, shares in Rossari Biotech were trading -11.12% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Rossari Biotech PE ratio based on its reported earnings over the past 12 months is 24.22. The shares last closed at IN₹699.35.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Rossari Biotech's management team is headed by:
- Edward Menezes - CHM
- Sunil Chari - CFD
- Manasi Nisal - CFO
- Parul Gupta - CCO
- Robin Banerjee - IND
- Goutam Bhattacharya - IND
- Meher Castelino - IND
- Aseem Dhru - IND
- Sharabh Pachory - IND